Author

Sudipta Biswas

Cleveland ClinicORCID 0000-0003-1235-364XUnclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Sudipta Biswas1 paper · Emory University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Babal Kant JhaiD· 1 shared Jaroslaw P. MaciejewskiiD· 1 shared Ramesh BalusuiD· 1 shared Songa BaeiD· 1 shared Xiaorong GuiD· 1 shared Yogen SaunthararajahiD· 1 shared Zeinab Albadry M. Zahran· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Babal Kant JhaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintJul 15, 2026

FLT3-ITD signals for CEBPA and p53 proteolysis by the ubiquitin-proteosome pathway

Xiaorong Gu, Sudipta Biswas, Zeinab Albadry M. Zahran…·Yogen Saunthararajah

This study shows FLT3-ITD promotes CEBPA and p53 proteolysis via the ubiquitin-proteosome pathway, blocking differentiation and apoptosis, and suggests UPP-inhibitors as therapeutic options.

DOI 10.64898/2026.07.14.738455

humanproteomics

𝕏 PostBluesky